index - Organisation de la cellule musculaire et thérapie de la myopathie centronucléaire autosomique dominante Accéder directement au contenu

Dernières publications

Chiffres clés

Chargement de la page

Open Access

55 %

Mots clés

Actin nucleus Core myopathy Centronuclear myopathy Gene therapy Caveolins Correlative microscopy Cytosquelette Cell proliferation Cavéoles Adeno-associated virus vector Clathrin Dystrophie musculaire d'Emery Dreifuss Myopathy Cardiotoxin Dynamine Actin Autosomal dominant centronuclear myopathy Allele specific RNA interference Nucleus Adhesion Cardiomyopathies Biomarkers A-type lamins BAF Clathrine Duchenne Muscular Dystrophy Developmental biology Cross-presentation Animal models of human disease ACTN2 Myopathie AD-CNM Disease modifiers Outflow tract Autophagy cellular Myosin Allele‐specific silencing therapy AAV8 Muscular dystrophy Cell signaling BMP signaling Muscle Biophysics CTL Allele-specific silencing Autophagosome maturation Cross-bridge kinetics Duchenne muscular dystrophy AAV DMyHC Dynamin overexpression Mechanotransduction Charcot-Marie-Tooth Neural crest cells Dullard Coeur Becker muscular dystrophy BMD Amphiphysin Dynamin 2 Cellular neuroscience Skeletal muscle Adeno-Associated virus CAV-3 gene Cellules de crête neurale Dynamin Skin Disease heterogeneity Caveolin Autophagy Autophagosome Allele-specific silencing therapy BAR proteins Migration Lamin Atrial cardiac defects Domaine LEM Adult patients Congenital myopathy DNM2 Cavins Developmental myosin heavy chain Cytoskeleton Diaphragm Endocytosis Nesprin AFM Antisense oligonucleotides Duchenne muscular dystrophy DMD RNA interference Nuclear envelope Cancer Dystrophie musculaire de Duchenne Ctdnep1 Adeno-associated virus Dominant centronuclear myopathy Caveolae Atrial heart defects Satellite cell Cell migration Alpha-actinin-2